Mesenchymal Stem Cells for Lupus: Understanding Their Potential and Limitations
A peer-reviewed review of research on mesenchymal stem cells in systemic lupus erythematosus, including potential uses, evidence, and limitations.
MSC
Literature Review: Do Mesenchymal Stem Cells Suppress Systemic Cytokines in Lupus and COPD?
A peer-reviewed review of studies examining mesenchymal stem cells, systemic cytokines, lupus, and COPD.
Mesenchymal Stem Cells and Neuroinflammation: Understanding the Role of the Secretome
A peer-reviewed review of research on mesenchymal stem cells, their secretome, and neuroinflammation in neurological disorders.
Can Regenerative Medicine Actually Repair Damaged Nerves?
Research suggests stem cell therapy may support nerve repair by calming inflammation, releasing growth factors, and encouraging Schwann cells to rebuild the protective myelin coating around damaged nerve fibers. Most of this evidence comes from lab and animal studies, with human research still developing. At Stemedix, we view stem cell treatment as one part of…
Umbilical Cord-Derived MSCs and Multiple Sclerosis: Exploring the Impact of Treatment Dose
Exploring a Different Approach to Multiple Sclerosis Multiple sclerosis, or MS, is a condition in which inflammation and abnormal immune activity damage the brain, spinal cord, and nerves over time. Current treatments can help control relapses and slow progression, but researchers continue to explore new approaches that may also support the body's natural repair processes.…
Literature Review: Mesenchymal Stem Cell Paracrine Signaling in Neuroinflammation
A peer-reviewed review of research on mesenchymal stem cell paracrine signaling, exosomes, and neuroinflammation.
Umbilical Cord-Derived MSCs and Type 1 Diabetes: Helping Preserve the Body’s Own Insulin Production
Protecting the Insulin the Body Can Still Make Type 1 diabetes develops when the immune system attacks the pancreatic beta cells responsible for producing insulin. By the time someone is diagnosed, many of these cells have already been lost, but some insulin-producing ability may still remain. Protecting that remaining function could potentially help slow the…
Umbilical Cord-Derived MSCs and Long-Term Recovery After Severe COVID-19
Looking at Recovery Years Later For some people who experienced severe COVID-19, recovery continued long after leaving the hospital. A 2025 study followed patients for three years after treatment with umbilical cord-derived mesenchymal stem cells, or UC-MSCs, to see how they were doing over the long term. The study focused not only on possible benefits,…
Umbilical Cord-Derived MSCs and Immune Thrombocytopenia: Exploring a New Approach to Immune Balance
When the Immune System Targets Platelets Platelets may be tiny, but they play an essential role in helping the blood clot and preventing excessive bleeding. In people with immune thrombocytopenia, or ITP, the immune system mistakenly attacks and destroys platelets faster than the body can replace them. When platelet levels become very low, patients may…
Can Combining Umbilical Cord MSCs Make Regenerative Therapies More Consistent?
Not All Stem Cells Behave Exactly the Same When we talk about umbilical cord-derived mesenchymal stromal cells, or UC-MSCs, it can be easy to think of them as one uniform type of cell. In reality, cells collected from different umbilical cords can behave differently in the laboratory. Some may grow faster, while others may be…
Do you have questions?
We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!